- Filed
- May 8, 2020 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · Apr 27, 2020 | 44.33M sh |
| Long Term Debt | Q1 2020 · Mar 31, 2020 | $264.89M |
| Long Term Debt | Q1 2020 · Dec 31, 2019 | $162.71M |
| Short Term Debt | Q1 2020 · Mar 31, 2020 | $972K |
| Short Term Debt | Q1 2020 · Dec 31, 2019 | $778K |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $145.92M |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $40.4M |
| Stockholders Equity | Q1 2020 · Mar 31, 2020 | $88M |
| Stockholders Equity | Q1 2020 · Dec 31, 2019 | $92.24M |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $159.71M |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $158.4M |
| Total Liabilities | Q1 2020 · Mar 31, 2020 | $614.14M |
| Total Liabilities | Q1 2020 · Dec 31, 2019 | $506.99M |
| Current Assets | Q1 2020 · Mar 31, 2020 | $221.65M |
| Current Assets | Q1 2020 · Dec 31, 2019 | $122.2M |
| Total Assets | Q1 2020 · Mar 31, 2020 | $703.09M |
| Total Assets | Q1 2020 · Dec 31, 2019 | $600.47M |
| Rd Expense | Q1 2020 · Mar 31, 2020 | $6.99M |
| Rd Expense | Q1 2020 · Mar 31, 2019 | $9M |
| Shares Diluted | Q1 2020 · Mar 31, 2019 | 43.53M sh |
| Capex | Q1 2020 · Mar 31, 2019 | $32.39M |
| Operating Cash Flow | Q1 2020 · Mar 31, 2019 | $23.74M |
| Eps Diluted | Q1 2020 · Mar 31, 2019 | −$0.12 |
| Eps Basic | Q1 2020 · Mar 31, 2019 | −$0.12 |
| Net Income | Q1 2020 · Mar 31, 2019 | −$5.15M |
| Operating Income | Q1 2020 · Mar 31, 2019 | −$3.37M |
| Revenue | Q1 2020 · Mar 31, 2019 | $66.47M |